1 Introduction to Research & Analysis Reports
    1.1 Oral Solid Dosage Contract Manufacturing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Oral Solid Dosage Contract Manufacturing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Oral Solid Dosage Contract Manufacturing Overall Market Size
    2.1 Global Oral Solid Dosage Contract Manufacturing Market Size: 2021 VS 2027
    2.2 Global Oral Solid Dosage Contract Manufacturing Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Oral Solid Dosage Contract Manufacturing Players in Global Market
    3.2 Top Global Oral Solid Dosage Contract Manufacturing Companies Ranked by Revenue
    3.3 Global Oral Solid Dosage Contract Manufacturing Revenue by Companies
    3.4 Top 3 and Top 5 Oral Solid Dosage Contract Manufacturing Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Oral Solid Dosage Contract Manufacturing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Oral Solid Dosage Contract Manufacturing Players in Global Market
        3.6.1 List of Global Tier 1 Oral Solid Dosage Contract Manufacturing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Oral Solid Dosage Contract Manufacturing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Oral Solid Dosage Contract Manufacturing Market Size Markets, 2021 & 2027
        4.1.2 Tablets
        4.1.3 Capsules
        4.1.4 Powders & Granules
        4.1.5 Others
    4.2 By Type - Global Oral Solid Dosage Contract Manufacturing Revenue & Forecasts
        4.2.1 By Type - Global Oral Solid Dosage Contract Manufacturing Revenue, 2016-2021
        4.2.2 By Type - Global Oral Solid Dosage Contract Manufacturing Revenue, 2022-2027
        4.2.3 By Type - Global Oral Solid Dosage Contract Manufacturing Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Oral Solid Dosage Contract Manufacturing Market Size, 2021 & 2027
        5.1.2 Specialty/Midsize
        5.1.3 Generics
        5.1.4 Big Pharma
        5.1.5 Other
    5.2 By Application - Global Oral Solid Dosage Contract Manufacturing Revenue & Forecasts
        5.2.1 By Application - Global Oral Solid Dosage Contract Manufacturing Revenue, 2016-2021
        5.2.2 By Application - Global Oral Solid Dosage Contract Manufacturing Revenue, 2022-2027
        5.2.3 By Application - Global Oral Solid Dosage Contract Manufacturing Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Oral Solid Dosage Contract Manufacturing Market Size, 2021 & 2027
    6.2 By Region - Global Oral Solid Dosage Contract Manufacturing Revenue & Forecasts
        6.2.1 By Region - Global Oral Solid Dosage Contract Manufacturing Revenue, 2016-2021
        6.2.2 By Region - Global Oral Solid Dosage Contract Manufacturing Revenue, 2022-2027
        6.2.3 By Region - Global Oral Solid Dosage Contract Manufacturing Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Oral Solid Dosage Contract Manufacturing Revenue, 2016-2027
        6.3.2 US Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.3.3 Canada Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.3.4 Mexico Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Oral Solid Dosage Contract Manufacturing Revenue, 2016-2027
        6.4.2 Germany Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.4.3 France Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.4.4 U.K. Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.4.5 Italy Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.4.6 Russia Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.4.7 Nordic Countries Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.4.8 Benelux Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Oral Solid Dosage Contract Manufacturing Revenue, 2016-2027
        6.5.2 China Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.5.3 Japan Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.5.4 South Korea Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.5.5 Southeast Asia Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.5.6 India Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Oral Solid Dosage Contract Manufacturing Revenue, 2016-2027
        6.6.2 Brazil Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.6.3 Argentina Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue, 2016-2027
        6.7.2 Turkey Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.7.3 Israel Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.7.4 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
        6.7.5 UAE Oral Solid Dosage Contract Manufacturing Market Size, 2016-2027
7 Players Profiles
    7.1 Catalent
        7.1.1 Catalent Corporate Summary
        7.1.2 Catalent Business Overview
        7.1.3 Catalent Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.1.4 Catalent Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.1.5 Catalent Key News
    7.2 DPx
        7.2.1 DPx Corporate Summary
        7.2.2 DPx Business Overview
        7.2.3 DPx Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.2.4 DPx Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.2.5 DPx Key News
    7.3 Lonza Group (Capsugel)
        7.3.1 Lonza Group (Capsugel) Corporate Summary
        7.3.2 Lonza Group (Capsugel) Business Overview
        7.3.3 Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.3.4 Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.3.5 Lonza Group (Capsugel) Key News
    7.4 Piramal Pharma Solutions
        7.4.1 Piramal Pharma Solutions Corporate Summary
        7.4.2 Piramal Pharma Solutions Business Overview
        7.4.3 Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.4.4 Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.4.5 Piramal Pharma Solutions Key News
    7.5 Aenova
        7.5.1 Aenova Corporate Summary
        7.5.2 Aenova Business Overview
        7.5.3 Aenova Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.5.4 Aenova Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.5.5 Aenova Key News
    7.6 Jubilant
        7.6.1 Jubilant Corporate Summary
        7.6.2 Jubilant Business Overview
        7.6.3 Jubilant Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.6.4 Jubilant Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.6.5 Jubilant Key News
    7.7 Famar
        7.7.1 Famar Corporate Summary
        7.7.2 Famar Business Overview
        7.7.3 Famar Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.4.4 Famar Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.7.5 Famar Key News
    7.8 Boehringer Ingelheim
        7.8.1 Boehringer Ingelheim Corporate Summary
        7.8.2 Boehringer Ingelheim Business Overview
        7.8.3 Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.8.4 Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.8.5 Boehringer Ingelheim Key News
    7.9 Fareva Holding
        7.9.1 Fareva Holding Corporate Summary
        7.9.2 Fareva Holding Business Overview
        7.9.3 Fareva Holding Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.9.4 Fareva Holding Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.9.5 Fareva Holding Key News
    7.10 AbbVie Contract Manufacturing
        7.10.1 AbbVie Contract Manufacturing Corporate Summary
        7.10.2 AbbVie Contract Manufacturing Business Overview
        7.10.3 AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.10.4 AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.10.5 AbbVie Contract Manufacturing Key News
    7.11 Nipro Pharma
        7.11.1 Nipro Pharma Corporate Summary
        7.11.2 Nipro Pharma Business Overview
        7.11.3 Nipro Pharma Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.11.4 Nipro Pharma Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.11.5 Nipro Pharma Key News
    7.12 Sopharma
        7.12.1 Sopharma Corporate Summary
        7.12.2 Sopharma Business Overview
        7.12.3 Sopharma Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.12.4 Sopharma Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.12.5 Sopharma Key News
    7.13 Mylan (DPT Laboratories)
        7.13.1 Mylan (DPT Laboratories) Corporate Summary
        7.13.2 Mylan (DPT Laboratories) Business Overview
        7.13.3 Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.13.4 Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.13.5 Mylan (DPT Laboratories) Key News
    7.14 Recipharm
        7.14.1 Recipharm Corporate Summary
        7.14.2 Recipharm Business Overview
        7.14.3 Recipharm Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.14.4 Recipharm Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.14.5 Recipharm Key News
    7.15 NextPharma
        7.15.1 NextPharma Corporate Summary
        7.15.2 NextPharma Business Overview
        7.15.3 NextPharma Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.15.4 NextPharma Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.15.5 NextPharma Key News
    7.16 Dishman
        7.16.1 Dishman Corporate Summary
        7.16.2 Dishman Business Overview
        7.16.3 Dishman Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.16.4 Dishman Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.16.5 Dishman Key News
    7.17 Aesica Pharmaceuticals
        7.17.1 Aesica Pharmaceuticals Corporate Summary
        7.17.2 Aesica Pharmaceuticals Business Overview
        7.17.3 Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.17.4 Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.17.5 Aesica Pharmaceuticals Key News
    7.18 CordenPharma
        7.18.1 CordenPharma Corporate Summary
        7.18.2 CordenPharma Business Overview
        7.18.3 CordenPharma Oral Solid Dosage Contract Manufacturing Major Product Offerings
        7.18.4 CordenPharma Oral Solid Dosage Contract Manufacturing Revenue in Global (2016-2021)
        7.18.5 CordenPharma Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer